Incidence and Risk Factors of Infectious Complications Related to Implantable Venous-Access Ports.
10.3348/kjr.2014.15.4.494
- Author:
Jisue SHIM
1
;
Tae Seok SEO
;
Myung Gyu SONG
;
In Ho CHA
;
Jun Suk KIM
;
Chul Won CHOI
;
Jae Hong SEO
;
Sang Cheul OH
Author Information
1. Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul 152-703, Korea. g1q1papa@korea.ac.kr
- Publication Type:Original Article
- Keywords:
Intravenous access;
Cancer patient;
Subcutaneous port;
Infection;
Complication
- MeSH:
Adolescent;
Adult;
Aged;
Aged, 80 and over;
Analysis of Variance;
Catheter-Related Infections/*epidemiology/microbiology;
Catheters, Indwelling/*adverse effects;
Female;
Hematologic Neoplasms/drug therapy;
Humans;
Incidence;
Male;
Middle Aged;
Neoplasms/drug therapy;
Palliative Care/statistics & numerical data;
Retrospective Studies;
Risk Factors;
Vascular Access Devices/*adverse effects;
Young Adult
- From:Korean Journal of Radiology
2014;15(4):494-500
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The purpose of this study was to determine the incidence and risk factors of infections associated with implantable venous access ports (IVAPs). MATERIALS AND METHODS: From August 2003 through November 2011, 1747 IVAPs were placed in our interventional radiology suite. One hundred forty four IVAPs were inserted in patients with hematologic malignancy and 1603 IVAPs in patients with solid tumors. Among them, 40 ports (23 women and 17 men; mean age, 57.1 years; range, 13-83) were removed to treat port-related infections. We evaluated the incidence of port-related infection, patient characteristics, bacteriologic data, and patient progress. Univariable analyses (t test, chi-square test, and Fisher's exact test) and multiple logistic regression analyses were used to determine the risk factors for IVAP related infection. RESULTS: Overall, 40 (2.3%) of 1747 ports were removed for symptoms of infection with an incidence rate of 0.067 events/1000 catheter-days. According to the univariable study, the incidences of infection were seemingly higher in the patients who received the procedure during inpatient treatment (p = 0.016), the patients with hematologic malignancy (p = 0.041), and the patients receiving palliative chemotherapy (p = 0.022). From the multiple binary logistic regression, the adjusted odds ratios of infection in patients with hematologic malignancies and those receiving palliative chemotherapy were 7.769 (p = 0.001) and 4.863 (p = 0.003), respectively. Microorganisms were isolated from 26 (65%) blood samples, and two of the most causative organisms were found to be Staphylococcus (n = 10) and Candida species (n = 7). CONCLUSION: The underlying hematologic malignancy and the state of receiving palliative chemotherapy were the independent risk factors of IVAP-related infection.
